Filing Details
- Accession Number:
- 0001209191-21-034685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-20 20:16:34
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-05-20 20:16:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651944 | Dermtech Inc. | DMTK | Services-Medical Laboratories (8071) | 842870849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1787129 | Enrico Picozza | C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-18 | 19,826 | $37.38 | 786,036 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-18 | 1,300 | $38.05 | 784,736 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-19 | 111,168 | $35.55 | 673,568 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-19 | 28,849 | $36.10 | 644,719 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-20 | 34,202 | $36.00 | 610,517 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-20 | 45,498 | $37.04 | 565,019 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Common Stock | Disposition | 2021-05-20 | 15,019 | $37.46 | 550,000 | No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
No | 4 | S | Indirect | By HLM Venture Partners IV, L.P. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,000 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $37.00 to $37.98, inclusive. The reported price reflects the weighted-average sale price.
- The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- This transaction was executed in multiple trades at prices ranging from $38.01 to $38.13, inclusive. The reported price reflects the weighted-average sale price.
- This transaction was executed in multiple trades at prices ranging from $35.00 to $35.99, inclusive. The reported price reflects the weighted-average sale price.
- This transaction was executed in multiple trades at prices ranging from $36.00 to $36.36, inclusive. The reported price reflects the weighted-average sale price.
- This transaction was executed in multiple trades at prices ranging from $35.29 to $36.28, inclusive. The reported price reflects the weighted-average sale price.
- This transaction was executed in multiple trades at prices ranging from $36.29 to $37.28, inclusive. The reported price reflects the weighted-average sale price.
- This transaction was executed in multiple trades at prices ranging from $37.30 to $37.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) through (8) of this Form 4.